Cambridge, MA, United States of America

Jesse Lyons

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Jesse Lyons

Introduction

Jesse Lyons, an accomplished inventor based in Cambridge, MA, has made significant contributions to the field of immunotherapy. With one patent to her name, she is at the forefront of a groundbreaking approach to enhance immune responses through her innovative work.

Latest Patents

Jesse's patent focuses on T cells surface-loaded with immunostimulatory fusion molecules and their uses. The patent details the development of immunostimulatory fusion molecules that comprise an immune cell targeting moiety and a cytokine molecule. It outlines the pharmaceutical formulations derived from these molecules, alongside the methods of using and manufacturing them. This invention holds great promise for advancing therapeutic strategies in immunology.

Career Highlights

Currently, Jesse Lyons is employed at Torque Therapeutics, Inc., a company dedicated to revolutionizing cancer treatment through innovative immunotherapeutic approaches. Her work plays a crucial role in the quest for more effective immunotherapies, highlighting her capabilities as a leading inventor in this dynamic field.

Collaborations

Throughout her career, Jesse has worked alongside talented colleagues such as Thomas Lars Andresen and De-Kuan Chang. These collaborations underscore the importance of teamwork in driving forward innovative solutions and achieving advancements in healthcare technology.

Conclusion

Jesse Lyons exemplifies the spirit of innovation and determination in the pursuit of cutting-edge medical technologies. Her patent and work at Torque Therapeutics demonstrate her commitment to improving immunotherapy, paving the way for new treatments that could significantly benefit patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…